November 16, 2022
Burning Rock Reports Third Quarter 2022 Financial Results
GUANGZHOU, China, Nov. 15, 2022 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or…
Pharmaceuticals, Biotechnology and Life Sciences
GUANGZHOU, China, Nov. 15, 2022 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or…
Science 37 is recognized for its unified platform to enable more patient-centric trialsRESEARCH TRIANGLE PARK, N.C., Nov. 15, 2022 (GLOBE…
BELTSVILLE, Md. and DAEJEON, South Korea, Nov. 15, 2022 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC) and LegoChem Biosciences, Inc. (LCB,…
PARIS and CAMBRIDGE, Mass., Nov. 15, 2022 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a…
Company to Host a Conference Call and Webcast on November 15, 2022, at 4:30 pm EDT POMPANO BEACH, FLORIDA., Nov. 15,…
Peer-reviewed article explains the immunology of the small intestinal axisCompany to hold a virtual Science Symposium on Wednesday, November 30,…
VANCOUVER, Nov. 14, 2022 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq and CSE: CMND), (FSE: CWY0) (“Clearmind” or the “Company”),…
–The MAA was submitted in the EU for toripalimab seeking indications for the 1st line treatment of NPC and the…
Reprioritization accelerating path to profitability Evaluation of partnership opportunities for select late-stage assets HONG KONG, SHANGHAI, China and FLORHAM PARK,…
NEW YORK, NY, AND TEL AVIV, ISRAEL, Nov. 14, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Todos Medical, Ltd. (OTCQB:…